Genmab A/S (GMAB)
27.66
-1.99
(-6.71%)
USD |
NASDAQ |
Mar 03, 16:00
27.91
+0.25
(+0.90%)
After-Hours: 06:47
Genmab Total Assets (Quarterly) : 12.87B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 133.96B |
| Novo Nordisk A/S | 85.37B |
| Krystal Biotech, Inc. | 1.334B |
| Ascendis Pharma A/S | 1.530B |
| Zealand Pharma A/S | 2.588B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.026B |
| Shareholders Equity (Quarterly) | 5.847B |
| Debt to Equity Ratio | 0.928 |
| Current Ratio | 2.022 |
| Net Debt Paydown Yield | -5.56% |